LP-195 Design of a Phase 2 study evaluating the efficacy and safety of nipocalimab in adult patients with active systemic lupus erythematosus

• Robert Hoffman,
• Robert Gordon,
• Federico Zazzetti,
• Terence Rooney,
• Jocelyn Leu,
• Anne Stevens,
• Sheng Gao,
• Qing Zuraw,
• Fang Liu-Walsh,
• Bart van Hartingsveldt,
• Cesar Calderon,
• George Vratsanos,
• YoungJa Lee

Affiliations

Robert Hoffman

1Immunology, Janssen Research and Development, USA

Robert Gordon

1Immunology, Janssen Research and Development, USA

Federico Zazzetti

4Immunology, Janssen-Cilag Argentina, Argentina

Terence Rooney

1Immunology, Janssen Research and Development, USA

Jocelyn Leu

1Immunology, Janssen Research and Development, USA

Anne Stevens

1Immunology, Janssen Research and Development, USA

Sheng Gao

1Immunology, Janssen Research and Development, USA

Qing Zuraw

1Immunology, Janssen Research and Development, USA

Fang Liu-Walsh

1Immunology, Janssen Research and Development, USA

Bart van Hartingsveldt

2Immunology, Janssen Biologics Europe, Netherlands

Cesar Calderon

1Immunology, Janssen Research and Development, USA

George Vratsanos

1Immunology, Janssen Research and Development, USA

YoungJa Lee

3Immunology, Janssen Asia Pacific, Republic of Korea